Herein, a series of CuI or CuNCS complexes with neocuproine (2,9-dimethyl-1,10-phenanthroline: dmp) and two tris(aminomethyl)phosphines derived from morpholine (P(CH2N(CH2CH2)2O)3) or thiomorpholine (P(CH2N(CH2CH2)2S)3) were tested as cytotoxic agents in vitro towards mouse colon carcinoma (CT26) and human lung adenocarcinoma (A549). The studies showed that the complexes exhibit potential antitumor properties, displayed by IC50 values below 10 μm towards the tested cell lines, in the case of 4-h incubation time with the examined compounds. Moreover, a high antimicrobial activity of all the complexes was observed against Staphylococcus aureus and Candida albicans with minimal inhibitory concentrations equal to 1–2 μg/mL. To gain insight into...
5-carbethoxy-2-thiouracil (eitotH2) reacts with CuX (X= Cl, Br, I) halides to give the formula [CuX(...
Novel mixed ligand bivalent copper complexes [Cu. L. A. ClO4] and [Cu. L. A] where “L” is Schiff bas...
Novel tetrahedral copper-(I) mixed-ligand complexes of the type [Cu-(X)-(N∩N)-(PCN)], 3-10, where X ...
Three new complexes of Cu(I) have been synthesized using ancillary ligands like thiopyrimidine (tp) ...
A series of copper(I)?phosphine polypyridyl complexes have been investigated as potential antitumor...
The copper(II) complex [Cu(tdp)(ClO4)]·0.5H2O (1), where H(tdp) is the tetradentate ligand 2-[(...
The cytotoxic properties of arylphosphines are regulated by metals. We have synthesized a series of ...
The mononuclear mixed ligand copper(II) complexes of the type [Cu(l-tyr)(diimine)](ClO4), where tyr ...
The cytotoxic properties of arylphosphines are regulated by metals. We have synthesized a series of ...
New copper(I) complexes [CuCl(PPh3)(L)] (1: L = LA = 4-carboxyphenyl)bis(3,5-dimethylpyrazolyl)metha...
In this article, cytotoxicity, the mechanisms of cytotoxic activity, genotoxicity, and interaction w...
An in situ reaction of CuCl2 center dot 2H(2)O, o-phenylenediamine, thiophene-2-carbaldehyde and sod...
The search for novel metal-based antitumor drugs other than Pt agents includes the investigation of ...
Six morpholine-(iso)thiosemicarbazone hybrids HL1-HL6 and their Cu(II) complexes with good-to-modera...
Four complexes, [Cu2(glyha)(bpy)2(H2O)]·2ClO4·H2O (1), [Cu2(glyha)(phen)2]·2ClO...
5-carbethoxy-2-thiouracil (eitotH2) reacts with CuX (X= Cl, Br, I) halides to give the formula [CuX(...
Novel mixed ligand bivalent copper complexes [Cu. L. A. ClO4] and [Cu. L. A] where “L” is Schiff bas...
Novel tetrahedral copper-(I) mixed-ligand complexes of the type [Cu-(X)-(N∩N)-(PCN)], 3-10, where X ...
Three new complexes of Cu(I) have been synthesized using ancillary ligands like thiopyrimidine (tp) ...
A series of copper(I)?phosphine polypyridyl complexes have been investigated as potential antitumor...
The copper(II) complex [Cu(tdp)(ClO4)]·0.5H2O (1), where H(tdp) is the tetradentate ligand 2-[(...
The cytotoxic properties of arylphosphines are regulated by metals. We have synthesized a series of ...
The mononuclear mixed ligand copper(II) complexes of the type [Cu(l-tyr)(diimine)](ClO4), where tyr ...
The cytotoxic properties of arylphosphines are regulated by metals. We have synthesized a series of ...
New copper(I) complexes [CuCl(PPh3)(L)] (1: L = LA = 4-carboxyphenyl)bis(3,5-dimethylpyrazolyl)metha...
In this article, cytotoxicity, the mechanisms of cytotoxic activity, genotoxicity, and interaction w...
An in situ reaction of CuCl2 center dot 2H(2)O, o-phenylenediamine, thiophene-2-carbaldehyde and sod...
The search for novel metal-based antitumor drugs other than Pt agents includes the investigation of ...
Six morpholine-(iso)thiosemicarbazone hybrids HL1-HL6 and their Cu(II) complexes with good-to-modera...
Four complexes, [Cu2(glyha)(bpy)2(H2O)]·2ClO4·H2O (1), [Cu2(glyha)(phen)2]·2ClO...
5-carbethoxy-2-thiouracil (eitotH2) reacts with CuX (X= Cl, Br, I) halides to give the formula [CuX(...
Novel mixed ligand bivalent copper complexes [Cu. L. A. ClO4] and [Cu. L. A] where “L” is Schiff bas...
Novel tetrahedral copper-(I) mixed-ligand complexes of the type [Cu-(X)-(N∩N)-(PCN)], 3-10, where X ...